Exencial Wealth Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.8K | Buy |
10,485
+26
| +0.2% | +$230 | ﹤0.01% | 485 |
|
|
2025
Q1 | $81.9K | Buy |
+10,459
| New | +$81.9K | ﹤0.01% | 491 |
|
|
2024
Q4 | – | Sell |
-25,000
| Closed | -$328K | – | 492 |
|
|
2024
Q3 | $328K | Buy |
25,000
+2,000
| +9% | +$26.2K | 0.01% | 416 |
|
|
2024
Q2 | $323K | Buy |
23,000
+7,700
| +50% | +$108K | 0.01% | 416 |
|
|
2024
Q1 | $258K | Buy |
15,300
+3,300
| +28% | +$55.7K | 0.01% | 451 |
|
|
2023
Q4 | $169K | Hold |
12,000
| – | – | 0.01% | 465 |
|
|
2023
Q3 | $124K | Buy |
+12,000
| New | +$124K | 0.01% | 414 |
|